The Center for Advanced Biological Therapeutics (CABT) is a BSL 2-compliant research facility. It focuses on next-generation biological therapeutics, mRNA modalities, and viral gene therapies like AAV.
Mr. GV Prasad, Co-Chairman & Managing Director, Dr. Reddy’s Laboratories in March 2024, inaugurated the facility designed to have an integrated, compliant ecosystem aimed to accelerate the development, production, and analysis of advanced biological therapeutics.
